Dr. Zane Cohen, C.M., is renowned for his innovative surgical methods, his practice-changing research, teaching and mentorship. Above all, he is beloved by the countless patients with inflammatory bowel disease (IBD) and colorectal cancer whose lives he has saved and improved over his 40-plus year career.
Now retired from surgery, he remains director of Mount Sinai Hospital’s Zane Cohen Centre for Digestive Diseases and professor of surgery at the University of Toronto. He continues to see patients and participate in research to refine techniques and improve care.
Serving as Mount Sinai’s Surgeon-in-Chief from 1990 to 2006, Dr. Cohen was Canada’s first surgeon to use novel surgical techniques for patients with ulcerative colitis. These techniques helped people resume normal lives, without the need for an external appliance to collect waste.
Dr. Cohen developed Canada’s first colorectal surgery training program at the University of Toronto. While chair of U of T’s division of general surgery, he initiated a gender neutrality policy to recruit the best and brightest female surgeons. The proportion of female surgeons in Toronto’s academic teaching hospitals subsequently rose from two percent to 40 percent.
Not only did Dr. Cohen establish one of the world’s largest research databases for patients with IBD, but he also developed the largest hereditary gastrointestinal cancer program in Canada. A new emphasis on testing and screening, developed at Mount Sinai and adopted widely, has helped prevent many cases of fatal colon cancer.
Recognized with numerous international honours, Dr. Cohen has also been a philanthropic leader, raising millions to support education and research in surgery. In addition, he has recently been awarded the Order of Ontario, and the Order of Canada.
Now retired from surgery, he remains director of Mount Sinai Hospital’s Zane Cohen Centre for Digestive Diseases and professor of surgery at the University of Toronto. He continues to see patients and participate in research to refine techniques and improve care.
Serving as Mount Sinai’s Surgeon-in-Chief from 1990 to 2006, Dr. Cohen was Canada’s first surgeon to use novel surgical techniques for patients with ulcerative colitis. These techniques helped people resume normal lives, without the need for an external appliance to collect waste.
Dr. Cohen developed Canada’s first colorectal surgery training program at the University of Toronto. While chair of U of T’s division of general surgery, he initiated a gender neutrality policy to recruit the best and brightest female surgeons. The proportion of female surgeons in Toronto’s academic teaching hospitals subsequently rose from two percent to 40 percent.
Not only did Dr. Cohen establish one of the world’s largest research databases for patients with IBD, but he also developed the largest hereditary gastrointestinal cancer program in Canada. A new emphasis on testing and screening, developed at Mount Sinai and adopted widely, has helped prevent many cases of fatal colon cancer.
Recognized with numerous international honours, Dr. Cohen has also been a philanthropic leader, raising millions to support education and research in surgery. In addition, he has recently been awarded the Order of Ontario, and the Order of Canada.
Now retired from surgery, he remains director of Mount Sinai Hospital’s Zane Cohen Centre for Digestive Diseases and professor of surgery at the University of Toronto. He continues to see patients and participate in research to refine techniques and improve care.
Serving as Mount Sinai’s Surgeon-in-Chief from 1990 to 2006, Dr. Cohen was Canada’s first surgeon to use novel surgical techniques for patients with ulcerative colitis. These techniques helped people resume normal lives, without the need for an external appliance to collect waste.
Dr. Cohen developed Canada’s first colorectal surgery training program at the University of Toronto. While chair of U of T’s division of general surgery, he initiated a gender neutrality policy to recruit the best and brightest female surgeons. The proportion of female surgeons in Toronto’s academic teaching hospitals subsequently rose from two percent to 40 percent.
Not only did Dr. Cohen establish one of the world’s largest research databases for patients with IBD, but he also developed the largest hereditary gastrointestinal cancer program in Canada. A new emphasis on testing and screening, developed at Mount Sinai and adopted widely, has helped prevent many cases of fatal colon cancer.
Recognized with numerous international honours, Dr. Cohen has also been a philanthropic leader, raising millions to support education and research in surgery. In addition, he has recently been awarded the Order of Ontario, and the Order of Canada.
Dr. Cohen is beloved by the countless patients with IBD and colorectal cancer whose lives he has saved and improved over his 40-plus year career.
About Mount Sinai 100 Chairs
In 2023, Mount Sinai Hospital will mark its 100th anniversary. To honour the physicians and scientists who have made breakthrough discoveries and whose achievements have elevated Sinai Health’s reputation for world-class care, we are pleased to introduce our Mount Sinai 100 Chairs. These legacy chairs carry the names of Sinai Health’s most eminent trailblazers and will help recruit and fund the work of a new generation of clinicians and scientists, securing the next century of caring at Sinai Health. We invite you to help us imagine the next 100 years.
About Mount Sinai 100 Chairs
In 2023, Mount Sinai Hospital will mark its 100th anniversary. To honour the physicians and scientists who have made breakthrough discoveries and whose achievements have elevated Sinai Health’s reputation for world-class care, we are pleased to introduce our Mount Sinai 100 Chairs. These legacy chairs carry the names of Sinai Health’s most eminent trailblazers and will help recruit and fund the work of a new generation of clinicians and scientists, securing the next century of caring at Sinai Health. We invite you to help us imagine the next 100 years.
About Mount Sinai 100 Chairs
In 2023, Mount Sinai Hospital will mark its 100th anniversary. To honour the physicians and scientists who have made breakthrough discoveries and whose achievements have elevated Sinai Health’s reputation for world-class care, we are pleased to introduce our Mount Sinai 100 Chairs. These legacy chairs carry the names of Sinai Health’s most eminent trailblazers and will help recruit and fund the work of a new generation of clinicians and scientists, securing the next century of caring at Sinai Health. We invite you to help us imagine the next 100 years.
